Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1/2 Open-label Study of TAK-850 Influenza Vaccine in Healthy Japanese Pediatric Subjects
jRCT2080222755Phase 2
- Sponsor
- Takeda
- Start
- Feb 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of TAK-850 in influenza (3 arms), sponsored by Takeda.
02
Drugs
TAK-850
03
Conditions
influenza
Beyond the preview
Go deeper on jRCT2080222755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222755.